The dominant narrative today about generative AI is that this technology will amplify privacy risks, but that is not always the case. In this webinar, Dr. Khaled El Emam will discuss the potential of generative AI to actually enhance the privacy of data.
On March 9, Stef James, Senior Director, Capability and Operations at AstraZeneca UK, joined EHIL to present her study of use cases for synthetic data within the pharmaceutical industry.
The Globe and Mail recently published the article, “Synthetic data puts privacy at the heart of AI projects” that features an interview with Dr. Khaled El Emam, head of the Electronic Health Information Laboratory.
To address the lagging commercialization of AI research in Canada, privacy laws must enable responsible access to data.
This is the opening statement for Khaled El Emam's appearance at the hearing on 7th February 2022.